Med Tech Alliance is comprised of corporate investors Accuron Technologies, Greatbatch, Inc. and Mr. Lu Yoh-Chie, Executive Chairman of Biosensors. This brings together 3 leaders in the med tech industry, each with over 30 years’ experience and together a combined sales of more than US$1 billion. This collective experience and corporate insight gives Med Tech Alliance the ability to shorten the learning curve for start-ups in the commercialisation process, and interpret and predict the market demand trends in tightening the focus for their investees.
The global presence of the Med Tech Alliance partners offers start-ups commercial channels into Europe, USA, and Asia. The accelerator also specialises in cardiovascular, orthopaedics, urology, diagnostics and ophthalmology sectors.
Learn more about our partners »Accuron Technologies Limited Greatbatch, Inc. Mr. Lu Yoh-Chie
Group Chief Executive Officer
Accuron Medical Technology
Chief Scientific Officer
Mr. Abel Ang is the Group Chief Executive Officer of Accuron Medical Technology, where he has overall responsibility for Accuron’s Medical Device activities.
Abel has a proven track record in the medical device sector. He has served as the Senior Advisor to the CEO of Greatbatch, Inc. (NYSE:GB), providing guidance relative to the commercialisation of medical device technologies in the cardiac, neurology, vascular and orthopaedic markets. Prior to Greatbatch, Abel was President, Asia/Pacific for Hill-Rom Inc. a US$1.7B revenue medical devices company (NYSE: HRC) where he was responsible for leading, developing and implementing the strategy to expand Hill-Rom's presence in the Asia/Pacific markets. He formerly served as the Chief Technology Officer for Hill-Rom for 3 years. In that role he had overall responsibility for Hill-Rom's global R&D operations which are distributed across sites in the U.S., Mexico, France, and Singapore. At Hill-Rom, he also held the positions of Vice-President and General Manager of Hill-Rom's US$420MM Global Surfaces and Therapy Business Unit; and Vice-President for International Business and Technology Development. He formerly headed the global Medical Technology and Biotechnology industry groups in the Singapore Economic Development Board's (EDB) Biomedical Division.
Mr. Ang has a Master of Science in Computational Biology from Rutgers University in New Jersey, which he pursued while on an EDB scholarship. He attended Harvard Business School's Advanced Management Program in 2012.
Daniel R. Kaiser holds the position of Chief Scientific Officer in Greatbatch, Inc. He was appointed to that position in June 2013. Prior to his current role, Mr. Kaiser has held several senior management roles in marketing and product development for both QiG Group and Greatbatch Medical. Before joining Greatbatch, Inc. in 2008, he has held positions of progressive responsibility developing and commercialising technology as an adjunct faculty member at the University of Minnesota and with Medtronic, Inc. and Guidant Corporation.
Dr. Kaiser currently resides in Plano, Texas with his wife and two sons.
Mr. Lu Yoh-Chie is a successful entrepreneur with over 30 years’ experience in the medical industry. He has extensive experience and knowledge on the medical technology market opportunities and strategies for commercialisation.